← Back to Search

Treatment (ICG lymphangiography) for Neck Dissection

N/A

Waitlist Available

Led By John Phay, MD

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Healthy adult patients who are undergoing LEFT modified radical or selective (including zone IV) lymph node dissection for any indication; this includes patients who have had prior neck surgery

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trial is testing a new way to see the thoracic duct during neck surgery, which may help prevent injury to it.

Eligible Conditions

Neck Dissection
Lymph Node Dissection

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Identify thoracic duct (TD) using indocyanine green (ICG)

Prevent injury to the TD

Recognize injury intra-operatively

Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment (ICG lymphangiography)Experimental Treatment2 Interventions

Participants receive indocyanine green solution SC and undergo near-infrared imaging over 1-2 minutes during their standard of care neck surgery.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Lymphangiography

2018

N/A

~130

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,639 Previous Clinical Trials

40,930,436 Total Patients Enrolled

Ohio State University Comprehensive Cancer CenterLead Sponsor

320 Previous Clinical Trials

290,159 Total Patients Enrolled

John Phay, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots for this experiment?

"Evidenced on clinicaltrials.gov, this examination is presently enrolling members. It was originally posted in April of 2018 with the latest update occurring in September 2022."

Answered by AI

What is the current scope of participants for this research undertaking?

"Confirmed. Clinicaltrials.gov records demonstrate that this clinical trial, which first became available on April 23rd 2018, is presently enrolling participants. 100 individuals are required across a single site for the study to be completed successfully."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery

John Phay, MD 2018. "Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03532581.